Back to search
H7276IntroducedRhode Islandhouse

Prohibits an insurance company from imposing any cost-sharing requirements for any diagnostic or supplemental breast examinations.

View official bill

Plain English Summary

AI-generated

Plain-English Summary

This bill would require health insurance companies in Rhode Island to cover diagnostic and supplemental breast examinations at no cost to the patient. That means if a doctor orders a follow-up mammogram, ultrasound, or other additional breast imaging — for example, because an initial screening showed something that needs a closer look — the insurance company could not charge the patient a copay, deductible, or any other out-of-pocket fee for those tests.

Currently, while many insurance plans already cover routine preventive breast cancer screenings without cost-sharing, patients can still face charges when they need a *diagnostic* exam (ordered because of a specific concern or abnormal result) or a *supplemental* exam (such as an MRI or ultrasound ordered in addition to a mammogram). This bill would close that gap, ensuring that cost does not become a barrier when a patient needs additional imaging to investigate a potential health concern.

This bill would primarily affect Rhode Island residents who have private health insurance and who are recommended by their doctor to get follow-up or additional breast imaging. Insurance companies operating in Rhode Island would be required to adjust their coverage policies to eliminate these cost-sharing charges. The bill has been referred to the House Health & Human Services Committee, which has recommended holding it for further study, meaning it has not yet advanced to a full vote.

This summary is AI-generated for informational purposes. Always refer to the official bill text for legal accuracy.

Sponsors

K
Kathleen FogartyD
L
Lauren CarsonD
M
Michelle McGawD
J
Jennifer BoylanD
J
Jenni Azanero FurtadoD
M
Mary MessierD
M
Maryann Shallcross-SmithD
C
Cherie CruzD
B
Brandon PotterD
S
Susan DonovanD

Legislative History

Committee recommended measure be held for further study

Feb 3, 2026

Scheduled for hearing and/or consideration (02/03/2026)

Jan 30, 2026

Introduced, referred to House Health & Human Services

Jan 23, 2026